Adjunctive intravenous immunoglobulins (IVIg) for moderate-severe COVID-19: emerging therapeutic roles
Curr Med Res Opin
.
2021 Jun;37(6):903-905.
doi: 10.1080/03007995.2021.1903849.
Epub 2021 Mar 31.
Authors
Felix Bongomin
1
,
Lucy Grace Asio
1
,
Kenneth Ssebambulidde
2
,
Joseph Baruch Baluku
3
4
Affiliations
1
Department of Medical Microbiology & Immunology, Faculty of Medicine, Gulu University, P.O. BOX, 166, Gulu, Uganda.
2
College of Health Sciences, Infectious Diseases Institute, Makerere University, Kampala, Uganda.
3
Division of Pulmonology, Kiruddu National Referral Hospital, Kampala, Uganda.
4
Directorate of Programs, Mildmay Uganda, Wakiso, Uganda.
PMID:
33722106
PMCID:
PMC8022334
DOI:
10.1080/03007995.2021.1903849
No abstract available
Publication types
Editorial
Grants and funding
D43 TW011401/TW/FIC NIH HHS/United States